Kush Patel

Director

In Vitro Diagnostics (IVD) companies are at the fore­front of revolutionizing healthcare by developing di­agnostic tools and tests that analyze samples such as blood or tissue outside the body. These companies play a crucial role in early disease detection, treatment monitor­ing, and personalized medicine. IVD technologies range from simple pregnancy tests to sophisticated molecular diagnostics, offering healthcare professionals valuable in­sights for accurate diagnoses. As pioneers in the intersec­tion of medicine and technology, IVD companies navigate challenges like regulatory compliance and market compe­tition, striving to improve patient outcomes and contribute to the advancement of global healthcare. Their innovations continue to shape the landscape of diagnostic medicine, enhancing the efficiency and effectiveness of medical in­terventions.

Similarly, in this ever-evolving landscape of healthcare, Nasmed Diagnostic stands as a beacon of innovation and quality. Contrary to the initial assumption that the company produces critical medical testing tools, Nasmed Diagnostic has carved its niche in manufacturing crucial pathology products such as blood collection tubes for day-to-day tests. With a CDSCO (Drug License) certification for manufacturing and distributing medical devices, Nasmed Diagnostic operates in the bustling city of Gandhinagar, Gujarat. The company's ISO 7 clean room facility ensures a controlled environment, safeguarding lab disposable products from pollutants.

“We have played a pivotal role in supplying high-quality lab disposable products like blood collection tubes and urine containers to leading healthcare institutions in India and neighboring countries. As the diagnostic market in India undergoes a transformative growth phase, Nasmed has strategically positioned itself to meet the increasing demand for healthcare products. The shift in mindset, with people opting for regular health checkups, has catalyzed the diagnostic market's expansion, expected to reach $2.2 billion by 2028 with a dynamic growth rate of 6.6 percent”, explains Kush Patel, Director, Nasmed Diagnostic.

Addressing Challenges in the Medical Industry

The healthcare industry faces challenges such as healthy competition, a shortage of skilled medical professionals, and infrastructure gaps, particularly in smaller towns. Nasmed Diagnostic acknowledges these hurdles and aims to contribute to the growth of the industry by focusing on the diagnostic market. The company's flagship products, Cell-Free DNA tubes for Non-Invasive Prenatal Testing (NIPT) and liquid oncology biopsy testing have witnessed substantial global growth, aligning with the increasing trend of comprehensive health testing.

Diversification & Quality Assurance as Pillars of Growth

Ensuring the quality and consistency of healthcare products is at the core of Nasmed Diagnostic's operations. The Quality Control (QC) and Quality Assurance (QA) teams follow stringent measures throughout the manufacturing process. From molding to assembly, packaging, and dispatch, every department has designated QC or QA personnel. The focus on documentation, aligned with the stringent CDSCO guidelines, reflects Nasmed Diagnostic's commitment to providing top-notch products.

“The post-COVID era has witnessed a paradigm shift in healthcare dynamics. India, emerging as a major exporter of generic pharmaceutical drugs, has also witnessed a shift from a price-sensitive market to a quality-sensitive one. Nasmed Diagnostic sees this as a positive development, aligning with stringent regulations and providing patients with high-quality healthcare products”, states Suril Shah, Director, Nasmed Diagnostic.

Future Goals

Therefore, Nasmed Diagnostic envisions a future marked by diversification. While currently entrenched in the diagnostic industry, the company aims to expand its products which will be used in pharmaceutical and microbiology industries. The goal is to create a diversified portfolio, acknowledging the interdependence of these industries and catering to a broader spectrum of healthcare needs. Additionally, Nasmed Diagnostic's commitment to innovation is also evident in its ongoing projects, including the development of an RNA testing tube. While details remain proprietary, the company boasts a robust research and development team comprising doctors, engineers, and PhDs. The aim is to contribute to the diagnostic and pharmaceutical markets by introducing cutting-edge products.

Hence, as Nasmed Diagnostic continues its journey, it sends a resounding message to consumers, healthcare professionals, and industry stakeholders. The company is not merely a player in the market; it is a harbinger of change, innovation, and uncompromising quality. With a team that blends business acumen, medical expertise, and years of experience, Nasmed Diagnostic is not just here to stay; it's here to lead and redefine the future of healthcare in India and beyond.